Month: April 2023

The 32nd annual Powwow, sponsored by the Brown School’s Kathryn M. Buder Center for American Indian Studies, will begin at 10 a.m. Saturday, April 22.

Richard W. (Dick) Coles, who served as the inaugural director of Tyson Research Center and also as an adjunct professor of biology for more than 25 years, died in December in Colorado. He was 83. A celebration of life for Coles is planned for 1 p.m. April 29 at Tyson Research Center in Eureka, Mo.

The inaugural recipient of the Kornitzer Distinguished Professorship will be Diana Z. O’Brien, a professor of political science in Arts & Sciences. She will be formally installed in a ceremony this fall.

A new partnership between the Weidenbaum Center and Harvard University will give social scientists at Washington University the opportunity to receive constructive, anonymous feedback on their research at any stage. The program aims to improve scholarship and speed its publication.

Images from on and around the Washington University campuses.

A special task force has formed to examine the climate and culture between faculty mentors and graduate and professional students or postdoctoral fellows on Washington University in St. Louis’ Danforth Campus, Provost Beverly Wendland announced.

Abhinav Jha, an assistant professor at the McKelvey School of Engineering and the School of Medicine, and his collaborators developed and evaluated two methods to quantitatively determine the realism of synthetic, or computer-generated, medical images.

The Performing Arts Department in Arts & Sciences will present “F***ing A,” Suzan-Lori Parks’ blistering riff on Nathaniel Hawthorne’s “The Scarlet Letter,” in the A.E. Hotchner Studio Theatre April 20-23.

The Earth is facing two interconnected crises — loss of biodiversity and climate change. Each separately is an enormous threat to life on this planet. However, together they are fueling each other, creating a worsening downward spiral.

A clinical trial led by the School of Medicine has shown that the investigational drug motixafortide — when combined with the standard therapy for mobilizing stem cells —may improve stem cell transplantation for multiple myeloma patients.